Related Experiment Video

Updated: Oct 17, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.0K

Recent Advances in Experimental Dendritic Cell Vaccines for Cancer

Ivan Y Filin1, Kristina V Kitaeva1, Catrin S Rutland2

  • 1Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.

Frontiers in Oncology
|October 11, 2021
PubMed

Insights

Dendritic cell (DC) vaccines show promise for cancer treatment, expanding applications and improving patient outcomes with low toxicity. Recent advances in DC vaccine research are enhancing their effectiveness in clinical trials.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Immunotherapy, including dendritic cell (DC) vaccines, has improved cancer treatment efficacy.
  • Initial applications of personalized DC vaccines yielded limited breakthroughs.
  • Advances in DC biology and antigen targeting have broadened their use.

Purpose of the Study:

  • To review novel approaches and recent progress in dendritic cell (DC) vaccine clinical trials.
  • To highlight the expanding applications and improved outcomes associated with DC vaccines.

Main Methods:

  • Review of recent scientific literature on dendritic cell (DC) vaccines.
  • Analysis of clinical trial data and advancements in DC vaccine technology.

Main Results:

  • Dendritic cell (DC) vaccines demonstrate expanding clinical applications.
  • Improved patient indicators and outcomes are observed with advanced DC vaccine strategies.
  • Low toxicity profiles are consistently reported in clinical trials.

Conclusions:

  • Dendritic cell (DC) vaccines represent a promising immunotherapeutic strategy for cancer.
  • Continued research and development are expanding the potential of DC vaccines in oncology.
  • The low toxicity of DC vaccines supports their wider adoption in clinical practice.
Keywords:
antigen-presenting cellsantitumor vaccinescancerdendritic cellsimmunotherapy

More Related Videos

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.4K
Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

3.6K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
564
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
741
Vaccinations01:51

Vaccinations

Overview
46.4K